Application Note: Screening for Amorphous Drug Substance
Source: SSCI Inc.
This Application Note suggests a strategy for finding the best amorphous form early in drug development, using small amounts of material, with the overall goal of reducing time to market. An amorphous material can be substantially more soluble than the corresponding crystalline material, as much as 1600 times more soluble according to a recent publication.
PDF format.
Published by: SSCI Inc.
access the Application Note!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.
Subscribe to Pharmaceutical Online
X
Subscribe to Pharmaceutical Online